TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Why Did Valeant Pharmaceuticals Intl Inc. Plunge Another 9%?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a target on its back.

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. Before its Earnings Report?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down 30% from recent highs. Is it a double-digit opportunity, or should you watch…

    Read more »

    The Motley Fool
    Investing

    2 Triple-Digit Stocks Worth Every Penny: Part 3

    Canadian Pacific Railway Limited (TSX:CP)(NYSE:CP) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have high stock prices, but they are both…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. a Buy After Recent Volatility?

    Due to the recent political fire, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) might be worth avoiding. But for riskier investors, it…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still a Good Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been in the cross hairs of the media recently, and the stock has tanked…

    Read more »

    The Motley Fool
    Investing

    Why Did Concordia Healthcare Corp. Shares Fall 50%?

    Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) shares have fallen by 50% since September 8th. Is this the opportunity of a lifetime?

    Read more »

    The Motley Fool
    Investing

    These 2 Oversold Healthcare Stocks Are too Cheap to Ignore Any Longer

    Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are oversold and could generate huge returns going forward. Which…

    Read more »

    The Motley Fool
    Investing

    Are Valeant Pharmaceuticals Intl Inc. and Concordia Healthcare Corp. Bargains After Crashing?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) have seen their share prices absolutely plunge.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc.’s 34% Decline an Opportunity to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has fallen 34% in two months. Is the high-growth pharmaceutical company a bargain or should…

    Read more »

    The Motley Fool
    Investing

    Concordia Healthcare Corp. and Valeant Pharmaceuticals Intl Inc. Suffer Big Declines

    The Democrats have their eyes on limiting drug-price increases. It's good for patients, but not so much for Valeant Pharmaceuticals…

    Read more »

    The Motley Fool
    Investing

    4 Dirty Secrets Bay Street Bankers Don’t Want You to Know

    Find out why you should be very wary of what Bay Street tells you, using Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX)…

    Read more »

    The Motley Fool
    Investing

    Should the Recession News Change Your Investing Strategy?

    The answer to Canada's recession is a properly diversified portfolio. This may mean reducing commodity names like Canadian Oil Sands…

    Read more »